Pagina de pornire532523 • BOM
add
Biocon Ltd
Închidere anterioară
318,65 ₹
Intervalul de astăzi
322,65 ₹ - 336,90 ₹
Interval anual
270,00 ₹ - 404,60 ₹
Capitalizare bursieră
403,68 mld. INR
Volum mediu
98,08 K
Raport P/E
49,95
Randamentul dividendelor
0,15 %
Bursă principală
NSE
La știri
Despre
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Director executiv
Înființare
1978
Site
Angajați
16.315